These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1451094)

  • 21. Abnormal microheterogeneity of haptoglobin in serum from dogs with various diseases.
    Andersson M; Sevelius E
    Vet Rec; 2001 Jan; 148(1):14-7. PubMed ID: 11200399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system.
    Kusama K; Okamoto Y; Saito K; Kasahara T; Murata T; Ueno Y; Kobayashi Y; Kamada Y; Miyoshi E
    Glycoconj J; 2017 Aug; 34(4):537-544. PubMed ID: 28455724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
    Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
    J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.
    Lin Z; Simeone DM; Anderson MA; Brand RE; Xie X; Shedden KA; Ruffin MT; Lubman DM
    J Proteome Res; 2011 May; 10(5):2602-11. PubMed ID: 21417406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbohydrate composition of the alpha-subunit of human choriogonadotropin (hCG alpha) and the free alpha molecules produced in pregnancy: most free alpha and some combined hCG alpha molecules are fucosylated.
    Blithe DL
    Endocrinology; 1990 Jun; 126(6):2788-99. PubMed ID: 1693562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis.
    Morishita K; Ito N; Koda S; Maeda M; Nakayama K; Yoshida K; Takamatsu S; Yamada M; Eguchi H; Kamada Y; Miyoshi E
    Clin Chim Acta; 2018 Dec; 487():84-89. PubMed ID: 30189188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
    Takeda Y; Shinzaki S; Okudo K; Moriwaki K; Murata K; Miyoshi E
    Cancer; 2012 Jun; 118(12):3036-43. PubMed ID: 22006099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment.
    Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Gallardo-Rincón D; Talamás-Rohana P
    Cell Adh Migr; 2015; 9(5):394-405. PubMed ID: 26211665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptoglobin typing and quantitation in normal Chinese females and gynecologic cancer patients.
    Ko TM; Su BT; May SY; Huang SC; Wen HK; Ouyang PC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):149-57. PubMed ID: 7449531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF].
    Zhao Q; Duan W; Wu YM; Qian XH; Deng XH
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):754-8. PubMed ID: 19173805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosylation and over-expression of endometriosis-associated peritoneal haptoglobin.
    Piva M; Moreno JI; Sharpe-Timms KL
    Glycoconj J; 2002 Jan; 19(1):33-41. PubMed ID: 12652078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative gas-liquid chromatography of neutral sugars in human serum glycoproteins. Fucose, mannose, and galactose as predictors in ovarian and small cell lung carcinoma.
    Gehrke CW; Waalkes TP; Borek E; Swartz WF; Cole TF; Kuo KC; Abeloff M; Ettinger DS; Rosenshein N; Young RC
    J Chromatogr; 1979 Apr; 162(4):507-28. PubMed ID: 528665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.
    Kamada Y; Kinoshita N; Tsuchiya Y; Kobayashi K; Fujii H; Terao N; Kamihagi K; Koyama N; Yamada S; Daigo Y; Nakamura Y; Taniguchi N; Miyoshi E
    Clin Chim Acta; 2013 Feb; 417():48-53. PubMed ID: 23262369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
    Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
    Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
    Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
    Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurements of haptoglobin by the reaction with concanavalin A in sera of patients with ovarian tumours.
    Katnik I; Jadach J; Kmieciak K; Gerber J; Dobryszycka W
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):727-32. PubMed ID: 8608195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affino-immunoelectrophoresis of haptoglobin with wheat germ agglutinin. Diagnostic significance in ovarian carcinoma.
    Katnik I; Gerber J; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):547-52. PubMed ID: 3439855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.
    Zhao C; Annamalai L; Guo C; Kothandaraman N; Koh SC; Zhang H; Biswas A; Choolani M
    Neoplasia; 2007 Jan; 9(1):1-7. PubMed ID: 17325738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.
    Miyoshi E; Shinzaki S; Moriwaki K; Matsumoto H
    Methods Enzymol; 2010; 478():153-64. PubMed ID: 20816478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
    Dobryszycka W; Gerber J; Zuwała-Jagiełło J; Ujec M
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):41-50. PubMed ID: 1725104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.